NCT02365766 · Interventional trial
Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects
Overall registry status Completed
Phase 1 · Phase 2
Conditions Bladder Cancer, Urothelial Carcinoma
Delaware Valley sites
- Thomas Jefferson University: Kimmel Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory